Fuwen Yuan

965 total citations
33 papers, 615 citations indexed

About

Fuwen Yuan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fuwen Yuan has authored 33 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Fuwen Yuan's work include RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (5 papers) and Prostate Cancer Treatment and Research (5 papers). Fuwen Yuan is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (5 papers) and Prostate Cancer Treatment and Research (5 papers). Fuwen Yuan collaborates with scholars based in China, United States and United Kingdom. Fuwen Yuan's co-authors include Tanjun Tong, William Hankey, Feng He, Qian Cheng, Qianben Wang, Qianqian Zhou, Yanhua Chen, Guodong Li, Ruolei Wang and Xiaosheng Fang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Fuwen Yuan

29 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuwen Yuan China 15 433 128 111 106 49 33 615
Ji Ma China 16 456 1.1× 174 1.4× 187 1.7× 152 1.4× 67 1.4× 45 786
Albert Hagelgans Germany 15 369 0.9× 137 1.1× 100 0.9× 60 0.6× 74 1.5× 27 653
Songbai Liu China 16 471 1.1× 121 0.9× 121 1.1× 60 0.6× 44 0.9× 74 755
Mengyao Sun China 15 414 1.0× 125 1.0× 97 0.9× 82 0.8× 76 1.6× 36 725
Fuwen Luo China 13 323 0.7× 88 0.7× 173 1.6× 68 0.6× 60 1.2× 26 647
Amy L. Silvers United States 10 360 0.8× 121 0.9× 132 1.2× 88 0.8× 63 1.3× 10 605
WEN-SHIN CHANG Taiwan 12 250 0.6× 158 1.2× 125 1.1× 57 0.5× 53 1.1× 74 527
Jufang Chi China 15 288 0.7× 79 0.6× 86 0.8× 77 0.7× 47 1.0× 26 579
Young‐Lan Park South Korea 17 382 0.9× 129 1.0× 171 1.5× 59 0.6× 106 2.2× 49 659

Countries citing papers authored by Fuwen Yuan

Since Specialization
Citations

This map shows the geographic impact of Fuwen Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuwen Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuwen Yuan more than expected).

Fields of papers citing papers by Fuwen Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuwen Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuwen Yuan. The network helps show where Fuwen Yuan may publish in the future.

Co-authorship network of co-authors of Fuwen Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Fuwen Yuan. A scholar is included among the top collaborators of Fuwen Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuwen Yuan. Fuwen Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hankey, William, et al.. (2025). Programmed Cell Death in Cancer. MedComm. 6(9). e70357–e70357. 1 indexed citations
2.
Yuan, Fuwen, Xiaojing Zhu, Fengjing Jia, et al.. (2025). Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment. Cancer Research. 85(21). 4081–4098. 1 indexed citations
3.
4.
Li, Haoze, Jiawei Gao, Xinglin Chen, et al.. (2024). Network pharmacology and experimental validation to explore the role and potential mechanism of Liuwei Dihuang Decoction in prostate cancer. BMC Complementary Medicine and Therapies. 24(1). 284–284. 2 indexed citations
5.
Zhou, Qianqian, Yanhua Chen, Jianguo Fu, et al.. (2024). Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest. Bioorganic Chemistry. 152. 107731–107731. 2 indexed citations
6.
Hou, Xinxin, Fengjing Jia, Yuan Yuan, et al.. (2023). Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway. Journal of Ethnopharmacology. 318(Pt A). 116866–116866. 41 indexed citations
7.
Jia, Fengjing, Qun Yu, Ruolei Wang, et al.. (2023). Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression. International Journal of Molecular Sciences. 24(2). 1469–1469. 23 indexed citations
8.
Chen, Yanhua, et al.. (2023). Qingdai Decoction suppresses prostate cancer growth in lethal-stage prostate cancer models. Journal of Ethnopharmacology. 308. 116333–116333. 9 indexed citations
9.
Wang, Ruolei, et al.. (2023). Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives. Pharmacological Research. 199. 107032–107032. 55 indexed citations
10.
Cui, Zhifen, Cong Zeng, Furong Huang, et al.. (2022). Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection. Nature Chemical Biology. 18(10). 1056–1064. 39 indexed citations
11.
Hou, Xinxin, Fengjing Jia, Fuwen Yuan, et al.. (2022). A High Hepatic Uptake of Conjugated Bile Acids Promotes Colorectal Cancer—Associated Liver Metastasis. Cells. 11(23). 3810–3810. 8 indexed citations
12.
Zhou, Qianqian, Yanhua Chen, Ruolei Wang, et al.. (2022). Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment. Genes & Diseases. 10(6). 2414–2424. 11 indexed citations
13.
Hankey, William, Benjamin Sunkel, Fuwen Yuan, et al.. (2020). Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range. Translational Oncology. 13(9). 100797–100797. 8 indexed citations
14.
Yuan, Fuwen, William Hankey, Eric J. Wagner, Wei Li, & Qianben Wang. (2019). Alternative polyadenylation of mRNA and its role in cancer. Genes & Diseases. 8(1). 61–72. 63 indexed citations
15.
Yuan, Fuwen, William Hankey, Dayong Wu, et al.. (2019). Molecular determinants for enzalutamide-induced transcription in prostate cancer. Nucleic Acids Research. 47(19). 10104–10114. 31 indexed citations
16.
Fu, Jingxuan, Daoyuan Huang, Fuwen Yuan, et al.. (2018). TRAF-interacting protein with forkhead-associated domain (TIFA) transduces DNA damage–induced activation of NF-κB. Journal of Biological Chemistry. 293(19). 7268–7280. 17 indexed citations
17.
Xie, Nan, Liwei Ma, Feng Zhu, et al.. (2016). Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress. Scientific Reports. 6(1). 36171–36171. 20 indexed citations
18.
Yuan, Fuwen, Qian Cheng, Guodong Li, & Tanjun Tong. (2015). Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis. PLoS ONE. 10(10). e0141678–e0141678. 11 indexed citations
19.
Ma, Liwei, Wenting Zhao, Feng Zhu, et al.. (2015). Global Characteristics of CSIG-Associated Gene Expression Changes in Human HEK293 Cells and the Implications for CSIG Regulating Cell Proliferation and Senescence. Frontiers in Endocrinology. 6. 69–69. 6 indexed citations
20.
Cheng, Qian, Xiaoxiao Cao, Fuwen Yuan, Guodong Li, & Tanjun Tong. (2014). Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53. Biochemical and Biophysical Research Communications. 448(3). 248–254. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji Ma Breakdown of academic impact, for papers by Albert Hagelgans Breakdown of academic impact, for papers by Songbai Liu Breakdown of academic impact, for papers by Mengyao Sun Breakdown of academic impact, for papers by Fuwen Luo Breakdown of academic impact, for papers by Amy L. Silvers Breakdown of academic impact, for papers by WEN-SHIN CHANG Breakdown of academic impact, for papers by Jufang Chi Breakdown of academic impact, for papers by Young‐Lan Park
Rankless by CCL
2026